Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia

Laurent Phely,Luca Hensen,Christoph Faul, Christer Alexander Ruff,Dina Schneider,Wolfgang Andreas Bethge,Claudia Lengerke

JAMA Oncology（2024）

引用 0|浏览0

暂无评分

摘要

This case series reports durable remissions in 2 patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with allogeneic bispecific CD19/CD22-targeting chimeric antigen receptor T cells.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要